Development of a Single-Step Antibody–Drug Conjugate Purification Process with Membrane Chromatography
Juan Carlos Cordova,Sheng Sun,Jeffrey Bos,Srinath Thirumalairajan,Sanjeevani Ghone,Miyako Hirai,Ricarda A. Busse,Julia S. v. der Hardt,Ian Schwartz,Jieyu Zhou
DOI: https://doi.org/10.3390/jcm10030552
IF: 3.9
2021-02-02
Journal of Clinical Medicine
Abstract:Membrane chromatography is routinely used to remove host cell proteins, viral particles, and aggregates during antibody downstream processing. The application of membrane chromatography to the field of antibody-drug conjugates (ADCs) has been applied in a limited capacity and in only specialized scenarios. Here, we utilized the characteristics of the membrane adsorbers, Sartobind® S and Phenyl, for aggregate and payload clearance while polishing the ADC in a single chromatographic run. The Sartobind® S membrane was used in the removal of excess payload, while the Sartobind® Phenyl was used to polish the ADC by clearance of unwanted drug-to-antibody ratio (DAR) species and aggregates. The Sartobind® S membrane reproducibly achieved log-fold clearance of free payload with a 10 membrane-volume wash. Application of the Sartobind® Phenyl decreased aggregates and higher DAR species while increasing DAR homogeneity. The Sartobind® S and Phenyl membranes were placed in tandem to simplify the process in a single chromatographic run. With the optimized binding, washing, and elution conditions, the tandem membrane approach was performed in a shorter timescale with minimum solvent consumption and high yield. The application of the tandem membrane chromatography system presents a novel and efficient purification scheme that can be realized during ADC manufacturing.
medicine, general & internal